Substantial increase in adsorption efficiency of local clay-alginate beads toward methylene blue impregnated with SDS.

In the current research work, local clay-alginate beads loaded with sodium dodecyl sulfate (SDS) surfactant were prepared for efficient adsorption of methylene blue (MB). FTIR, SEM-EDX, and TGA instruments were used to examine the surface functional groups, morphology, elemental analysis, and thermal stability of beads, respectively. The adsorption efficiency of native clay for MB increases from 124.78 to 247.94 mg/g when loaded in alginate and SDS in beads form. The impacts of adsorbent dosage, initial pH, contact time, initial MB concentration, and temperature were investigated and optimized. The maximum adsorption capacity of beads for MB was 1468.5 mg/g. The process followed a pseudosecond order kinetic and Freundlich adsorption isotherm model. Thermodynamic study confirmed that MB adsorption on beads is endothermic and spontaneous in nature. The beads were recycled and reused for five times. According to the findings, local clay-alginate beads impregnated with SDS proved to be a promising and efficient adsorbent for extracting MB from aqueous solution.

Fabrication of a lead-free ternary ceramic system for high energy storage applications in dielectric capacitors.

The importance of electroceramics is well-recognized in applications of high energy storage density of dielectric ceramic capacitors. Despite the excellent properties, lead-free alternatives are highly desirous owing to their environmental friendliness for energy storage applications. Herein, we provide a facile synthesis of lead-free ferroelectric ceramic perovskite material demonstrating enhanced energy storage density. The ceramic material with a series of composition (1-z) (0.94Na0.5Bi0.5TiO3-0.06BaTiO3)-zNd0.33NbO3, denoted as NBT-BT-zNN, where, z = 0.00, 0.02, 0.04, 0.06, and 0.08 are synthesized by the conventional solid-state mix oxide route. Microphases, microstructures, and energy storage characteristics of the as-synthesized ceramic compositions were determined by advanced ceramic techniques. Powder X-ray diffraction analysis reveals pure single perovskite phases for z = 0 and 0.02, and secondary phases of Bi2Ti2O7 appeared for z = 0.04 and 0.08. Furthermore, scanning electron microscopy analysis demonstrates packed-shaped microstructures with a reduced grain size for these ceramic compositions. The coercive field (Ec) and remnant polarization (Pr) deduced from polarization vs. electric field hysteresis loops determined using an LCR meter demonstrate decreasing trends with the increasing z content for each composition. Consequently, the maximum energy storage density of 3.2 J/cm3, the recoverable stored energy of 2.01 J/cm3, and the efficiency of 62.5% were obtained for the z content of 2 mol% at an applied electric field of 250 kV/cm. This work demonstrates important development in ceramic perovskite for high power energy storage density and efficiency in dielectric capacitors in high-temperature environments. The aforementioned method makes it feasible to modify a binary ceramic composition into a ternary system with highly enhanced energy storage characteristics by incorporating rare earth metals with transition metal oxides in appropriate proportions.

Anti-neuropathic pain activity of a cationic palladium (II) dithiocarbamate by suppressing the inflammatory mediators in paclitaxel-induced neuropathic pain model.

BACKGROUND: Neuropathic pain is a chronic pain state that negatively impacts the quality of life. Currently, available therapies for the treatment of neuropathic pain often lack efficacy and tolerability. Therefore, the search for novel drugs is crucial to obtain treatments that effectively suppress neuropathic pain. OBJECTIVES: The present study was undertaken to investigate the antinociceptive properties of (1,4-bis-(diphenylphosphino) butane) palladium (II) chloride monohydrate (Compound 1) in a paclitaxel (PTX)-induced neuropathic pain model. METHODS: Initially, behavioral tests such as mechanical and cold allodynia as well as thermal and tail immersion hyperalgesia were performed to investigate the antinociceptive potential of Compound 1 (5 and 10 mg/kg, b.w). RT-PCR was performed to determine the effect of Compound 1 on the mRNA expression level of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and proinflammatory cytokines such as tumor necrosis factor-alpha (TNF)-α, interleukin (IL)-1ß, and IL-6. In addition, antioxidant protein, nitric oxide (NO), and malondialdehyde (MDA) levels were also determined. RESULTS: The results demonstrated that once-daily dosing of Compound 1 significantly suppressed the PTX-induced behavioral pain responses dose-dependently. The mRNA gene expressions of iNOS, COX-2, and inflammatory cytokines were markedly reduced by Compound 1. Furthermore, it enhanced the level of antioxidant enzymes and lowered the level of MDA and NO production. CONCLUSION: These findings suggest that the antinociceptive potential of Compound 1 in the PTX-induced neuropathic pain model is via suppression of oxidative stress and inflammation. Thus, Compound 1 might be a potential candidate for the therapeutic management of PTX induced neuropathic pain.

Kinetic and toxicological effects of synthesized palladium(II) complex on snake venom (Bungarus sindanus) acetylcholinesterase.

BACKGROUND: The venom of the krait (Bungarus sindanus), an Elapidae snake, is highly toxic to humans and contains a great amount of acetylcholinesterase (AChE). The enzyme AChE provokes the hydrolysis of substrate acetylcholine (ACh) in the nervous system and terminates nerve impulse. Different inhibitors inactivate AChE and lead to ACh accumulation and disrupted neurotransmission. METHODS: The present study was designed to evaluate the effect of palladium(II) complex as antivenom against krait venom AChE using kinetics methods. RESULTS: Statistical analysis showed that krait venom AChE inhibition decreases with the increase of Pd(II) complex (0.025-0.05 µM) and exerted 61% inhibition against the AChE at a fixed concentration (0.5 mM) of ACh. Kinetic analysis using the Lineweaver Burk plot showed that Pd(II) caused a competitive inhibition. The compound Pd(II) complex binds at the active site of the enzyme. It was observed that K m (Michaelis-Menten constant of AChE-ACh into AChE and product) increased from 0.108 to 0.310 mM (45.74 to 318.35%) and V max remained constant with an increase of Pd(II) complex concentrations. In AChE K Iapp was found to increase from 0.0912 to 0.025 µM (29.82-72.58%) and did not affect the V maxapp with an increase of ACh from (0.05-1 mM). K i (inhibitory constant) was estimated to be 0.029 µM for snake venom; while the K m was estimated to be 0.4 mM. The calculated IC50 for Pd(II) complex was found to be 0.043 µM at constant ACh concentration (0.5 mM). CONCLUSIONS: The results show that the Pd(II) complex can be deliberated as an inhibitor of AChE.

Activated carbon-alginate beads impregnated with surfactant as sustainable adsorbent for efficient removal of methylene blue.

A cost-effective and sustainable Calligonum polygonoides biomass based activated carbon (AC) was synthesized. The prepared AC was utilized in the fabrication of carbon-alginate beads for the adsorption of methylene blue (MB) textile dye from aqueous solution. The surface morphology, surface functional groups, elemental analysis and thermal behavior of the prepared beads were investigated using different analytical techniques. Batch adsorption experiments were performed to investigate the adsorption capacity of the beads. Effect of different parameters such as initial pH of MB solution, dose of adsorbent, contact time, initial concentration of MB and temperature were evaluated. The kinetic studies identified pseudo-second order model. Langmuir and Freundlich isotherm models were applied and fitted to the experimental equilibrium data. The beads showed a maximum adsorption capacity of 769 mg/g in basic pH at 30 °C while using 400 mg·L-1 of MB solution. The adsorption process was found to be endothermic and spontaneous as confirmed by the thermodynamic data. The fabricated beads were subjected to recycling which exhibited same adsorption efficiency after six regeneration cycles. The results showed that the AC-alginate beads impregnated with SDS have high adsorption capability and would be used for the efficient removal of cationic dyes from wastewater.

Kinetic and toxicological effects of synthesized palladium(II) complex on snake venom (Bungarus sindanus) acetylcholinesterase

The venom of the krait (Bungarus sindanus), an Elapidae snake, is highly toxic to humans and contains a great amount of acetylcholinesterase (AChE). The enzyme AChE provokes the hydrolysis of substrate acetylcholine (ACh) in the nervous system and terminates nerve impulse. Different inhibitors inactivate AChE and lead to ACh accumulation and disrupted neurotransmission. Methods: The present study was designed to evaluate the effect of palladium(II) complex as antivenom against krait venom AChE using kinetics methods. Results: Statistical analysis showed that krait venom AChE inhibition decreases with the increase of Pd(II) complex (0.025-0.05 µM) and exerted 61% inhibition against the AChE at a fixed concentration (0.5 mM) of ACh. Kinetic analysis using the Lineweaver Burk plot showed that Pd(II) caused a competitive inhibition. The compound Pd(II) complex binds at the active site of the enzyme. It was observed that K m (Michaelis-Menten constant of AChE-ACh into AChE and product) increased from 0.108 to 0.310 mM (45.74 to 318.35%) and V max remained constant with an increase of Pd(II) complex concentrations. In AChE K Iapp was found to increase from 0.0912 to 0.025 µM (29.82-72.58%) and did not affect the V maxapp with an increase of ACh from (0.05-1 mM). K i (inhibitory constant) was estimated to be 0.029µM for snake venom; while the K m was estimated to be 0.4 mM. The calculated IC50 for Pd(II) complex was found to be 0.043 µM at constant ACh concentration (0.5 mM). Conclusions: The results show that the Pd(II) complex can be deliberated as an inhibitor of AChE.(AU)

A new cationic palladium(II) dithiocarbamate exhibits anti-inflammatory, analgesic, and antipyretic activities through inhibition of inflammatory mediators in in vivo models.

Inflammation is being a protective mechanism of the body towards the injury. However, chronic and progressive inflammation may lead to some chronic diseases. Due to the serious unwanted effects associated with available drugs, new and safe anti-inflammatory agents are still required. Therefore, the present study was designed to investigate the anti-inflammatory, analgesics, and antipyretic properties of a new compound (4-benzylpiperidine-1-carbodithioato-κ2S,S')(1,4-bis-(diphenylphosphino)butane)palladium(II)chloride monohydrate (compound-1) in albino mice models. Compound-1 was characterized by elemental analysis, FT-IR, and multinuclear NMR spectroscopy. Initially, compound-1 was evaluated for cytotoxicity, anti-inflammatory, and analgesic activities by performing MTT assay, carrageenan-, histamine-, serotonin-, and CFA-induced paw edema, mechanical hyperalgesia, thermal hyperalgesia, and mechanical allodynia (0.1, 1, and 10 mg/kg, b.w). Antipyretic activity was evaluated in brewer's yeast-induced model. The pro-inflammatory cytokines were measured by using commercially available ELISA kits. Additionally, nitrite production, antioxidant enzymes, H&E staining, muscle activity and motor coordination, and kidney and liver function tests were also determined. The results demonstrated that compound-1 significantly inhibited inflammation, pain, and febrile responses in all models at a dose of 10 mg/kg without effecting viability of cells in vitro at concentrations up to 100 µM. Similarly, the data clearly demonstrated significant reduction in the pro-inflammatory cytokines and nitrite production while enhancing antioxidant enzymes. Furthermore, pretreatment with compound-1 did not produce any prominent side effect on kidney, liver, stomach, and muscles. These findings suggest that compound-1 has potent anti-inflammatory-, pain-, and pyrexia-relieving properties. Hence, compound-1 might be a potential candidate for the therapeutic management of chronic inflammation and pain.

Synthesis, spectroscopic characterization, crystal structure, DNA interaction study and invitro biological screenings of 4-(5-chloro-2-hydroxyphenylamino)-4-oxobut-2-enoic acid.

The titled compound, 4-(5-chloro-2-hydroxyphenylamino)-4-oxobut-2-enoic acid was synthesized and characterized by various techniques like elemental analyses, FT-IR, NMR ((1)H, and (13)C) and single crystal X-ray structural analysis. The appearance of the OH peak of the carboxylic acid in the FT-IR and NMR spectra conform the formation of the compound. A good agreement was found between the calculated values of C, H, N and found values in elemental analysis that show the purity of the compound. Protons H2 and H3 are in cis conformation with each other as conformed both from (1)H NMR as well as from single crystal X-ray analysis. The molecular structure of the title compound, C10H10NO3Cl, is stabilized by short intramolecular OH---O hydrogen bonds within the molecule. In the crystal structure, intermolecular NH---O hydrogen bonds link molecules into zigzag chains resulting in a dendrimer like structure. The title compound was screened for biological activities like interaction with DNA, cytotoxicity, antitumor and antioxidant activities. DNA interaction study reveals that the binding mode of interaction of the compound with SS-DNA is intercalative as it results in hypochromism along with significant red shift of 5 nm. It was also found to be effective antioxidant of 2,2-diphenyl-1-picrylhydrazyl radical (DPPH) and show almost comparable antioxidant activity to that of the standard and known antioxidant, ascorbic acid, at higher concentration. The antitumor activity data of the compound shows that it can be used as potent antitumor agent.